Thomas Michael Thestrup

Thomas Michael Thestrup serves as Senior Principal at Angelini Ventures since September 2022, focusing on corporate venture investments in biotech, therapeutic medtech, and digital health. Additional roles include Board Member at Avation Medical, Board Member at Stealth Mode Biotech, and Board Observer positions at GenEp Inc., Arclight Therapeutics, and Cadence Neuroscience Inc. Previously, Thomas held the position of Corporate Venturing Investment Director at Angelini Pharma and co-founded Jymmin, a health tech company. Educational qualifications include a Ph.D. in neuroscience and protein engineering from the Max Planck Institute and a Master's in Biology and Biotechnology from the University of Copenhagen.